03Oct
03Oct
New technology may aid emergency preparedness
The Department of Health and Human Services (HHS) has earmarked funds to aid the development of new technology that could bolster emergency preparedness by producing platelets outside the human body. If the two-year, $4.9 million agreement between HHS Biomedical Advanced Research and Development Authority (BARDA) and Platelet BioGenesis, Inc. (PBG) of Cambridge, Mass., produces the desired results, the technology would improve emergency preparedness by making additional blood products available to save lives during a radiological or nuclear emergency.
03Oct
Emovi Announces Results of Clinical Trial to Manage Knee Osteoarthritis with KneeKGTM
Today, Emovi, Inc. announces positive results from a randomized, controlled trial involving KneeKG™, Emovi’s flagship medical device and the first device that enables healthcare professionals to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. Read more >>
02Oct
Corbion, KnipBio score wins for their alternative aquafeeds
Corbion and KnipBio each secured positive developments recently in the advancement of the development and marketing of their alternative aquafeed ingredients. Read more >>
02Oct
Wasabi scores ‘most important deal’ yet with Japanese telecom giant
Boston-based Wasabi Technologies, Inc. has scored a partnership and an investment that will pave the cloud storage provider’s way to the Japanese market in a deal that serial entrepreneur and CEO David Friend called “the most important business deal we’ve done since starting the company.” Read more >>
01Oct
Platelet BioGenesis Receives $56 Million Contract from BARDA
Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure. Read more >>
28Sep
IP is a very big deal for a technology company like ours, it’s essentially our currency in many ways,’ says KnipBio
The EU Patent Office has granted US innovator, KnipBio, a patent on the company’s intellectual property relating to the production of its single-cell protein for use in aquaculture and animal feeds, says CEO. Read more >>
27Sep
How FutureFuel.io is combating the student debt crisis
FutureFuel.io is combating the student debt crisis. CEO Laurel Taylor joins Yahoo Finance's Zack Guzman, Kristin Myers, and Wall Street Journal Wealth Reporter Veronica Dagher, to discuss. Read more >>
27Sep
Zylö Therapeutics Closes $4 Million Series A Financing
Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected a closing of its Series A financing through the sale of $4 million of Series A preferred shares. Read more >>
27Sep